GTBP — GT BIOPHARMA INC
As of Q2 2026, 8 SEC-registered investment managers reported holding GTBP (GT BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $210.15K across 429.12K shares. That is -4.3% by share count (-19.52K shares) versus the previous quarter, while reported value moved +14.8%. Ownership is concentrated: the five largest holders account for 98.1% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 1 added to existing stakes, 3 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
GTBP is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Geode Capital Management history | Q2 2026 | 266.79K | $130.65K | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2025 | 26.30K | $94.15K | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 75.46K | $36.95K | 0.00% | New |
| Citadel Advisors history | Q1 2026 | 66.17K | $27.00K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 40.00K | $19.60K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 22.57K | $11.05K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 15.99K | $7.83K | 0.00% | Hold |
| Vanguard Group history | Q3 2025 | 10.50K | $6.25K | 0.00% | Hold |
| BlackRock Inc history | Q2 2026 | 8.31K | $4.07K | 0.00% | Reduce |
| Citigroup Inc history | Q4 2025 | 2.78K | $2.18K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q1 2026 | 1.00K | $408 | 0.00% | New |
| Bank of America Corp history | Q4 2025 | 24 | $19 | 0.00% | Hold |
| UBS Group AG history | Q2 2026 | 2 | $1 | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 1 | $0 | — | New |
New Positions (Q2 2026)
- Northern Trust Corp 75.46K sh · $36.95K
- PNC Financial Services 40.00K sh · $19.60K
- JPMorgan Chase & Co 1 sh · $0
Fully Exited (vs previous quarter)
- Citadel Advisors sold 66.17K sh · $27.00K
- Fidelity Management & Research (FMR) sold 1.00K sh · $408
Fund Position History — shares by quarter (top 14 funds)
| Fund | Q2 2022 | Q1 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | — | — | 11.18K | 11.18K | 15.04K | 14.90K | 23.09K | 23.84K | 23.97K | 19.26K | 294.46K | 266.79K |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | — | — | 75.46K |
| PNC Financial Services | — | — | — | — | — | — | — | — | — | — | — | 40.00K |
| Morgan Stanley | — | — | 266 | 266 | 266 | 3.53K | 3.53K | 4.01K | 14.02K | 18.60K | 16.60K | 22.57K |
| Wells Fargo & Co | — | — | 10.02K | 10.01K | 10.01K | 10.01K | 10.01K | 10.01K | 10.01K | 16.04K | 16.04K | 15.99K |
| BlackRock Inc | — | — | — | — | 9.74K | 9.74K | 9.74K | 9.74K | 9.74K | 8.41K | 8.41K | 8.31K |
| UBS Group AG | — | — | 1.02K | 8.98K | 3.90K | 5.00K | 2.56K | 5.81K | 2.63K | 1 | 45.97K | 2 |
| Citadel Advisors | — | — | — | — | — | — | 20.14K | — | 39.63K | 80.76K | 66.17K | — |
| Fidelity Management & Research (FMR) | — | — | 61 | — | — | — | — | — | — | — | 1.00K | — |
| JPMorgan Chase & Co | 63.00K | 10.00K | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | — | 1 |
| Bank of America Corp | — | — | 17 | 27 | 27 | 27 | 27 | 29 | 24 | 24 | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | 2.78K | — | — |
| Vanguard Group | — | — | 20.51K | 10.50K | 10.50K | 10.50K | 10.50K | 10.50K | 10.50K | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | 26.30K | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details